KERNEL-BASED MULTI-TASK JOINT SPARSE CLASSIFICATION FOR ALZHEIMER'S DISEASE

Yaping Wang1, Manhua Liu2, Lei Guo3

  • 1School of Automation, Northwestern Polytechnical University, Xi'an, Shaanxi Province, China ; Department of Radiology and BRIC, University of North Carolina at Chapel Hill, USA.

Insights

This study introduces a new kernel-based model combining MRI and PET scans for diagnosing Alzheimer's disease (AD) and mild cognitive impairment (MCI). The method significantly improves classification accuracy, aiding in early detection of neurodegenerative disorders.

Area of Science:

  • Neuroimaging
  • Machine Learning
  • Medical Diagnostics

Background:

  • Neurodegenerative disorders like Alzheimer's disease (AD) and mild cognitive impairment (MCI) require accurate diagnostic tools.
  • Multi-modality imaging, such as MRI and PET, offers complementary data for enhanced diagnostic capabilities.

Purpose of the Study:

  • To develop and evaluate a novel kernel-based multi-task sparse representation model for improved classification of AD and MCI.
  • To leverage the combined strengths of MRI and PET imaging features for more precise diagnosis.

Main Methods:

  • Proposed a kernel-based multi-task sparse representation model integrating MRI and PET data.
  • Employed multi-task learning to enforce class-level joint sparsity across imaging modalities.
  • Extended the framework to the reproducing kernel Hilbert space (RKHS) to capture nonlinear feature relationships.

Main Results:

  • Achieved 93.3% accuracy in classifying Alzheimer's disease (AD) from healthy controls.
  • Attained 78.9% accuracy in classifying mild cognitive impairment (MCI) from healthy controls.
  • Demonstrated the model's effectiveness using the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.

Conclusions:

  • The proposed kernel-based multi-task sparse representation model shows significant promise for the accurate classification of AD and MCI.
  • Combining multi-modality imaging data through advanced sparse representation techniques enhances diagnostic performance.
  • This approach offers a valuable tool for early detection and study of neurodegenerative disorders.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
9.4K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K